These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 5057463)
1. Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates. Finlayson JS; Mosesson MW; Bronzert TJ; Pisano JJ J Biol Chem; 1972 Aug; 247(16):5220-2. PubMed ID: 5057463 [No Abstract] [Full Text] [Related]
2. Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. Mosesson MW; Finlayson JS; Umfleet RA; Galanakis D J Biol Chem; 1972 Aug; 247(16):5210-9. PubMed ID: 4262568 [No Abstract] [Full Text] [Related]
3. Cross-linking of fibrin by fibrin=stabilizing factor. McKee PA; Schwartz ML; Pizzo SV; Hill RL Ann N Y Acad Sci; 1972 Dec; 202():127-48. PubMed ID: 4565368 [No Abstract] [Full Text] [Related]
4. Human fibrinogen heterogeneities. 3. Identification of chain variants. Mosesson MW; Finlayson JS; Umfleet RA J Biol Chem; 1972 Aug; 247(16):5223-7. PubMed ID: 5057464 [No Abstract] [Full Text] [Related]
5. Polypeptide chains of human fibrin: molecular organization in cross-linking. McDonagh RP; McDonagh J; Blombäck B Ann N Y Acad Sci; 1972 Dec; 202():335-40. PubMed ID: 4508931 [No Abstract] [Full Text] [Related]
6. Localisation of carbohydrate in the subunits of human fibinogen and its plasmin induced fragments. Gaffney PJ Biochim Biophys Acta; 1972 Apr; 263(2):453-8. PubMed ID: 4113166 [No Abstract] [Full Text] [Related]
7. Plasmic degradation of human fibrinogen. I. Structural characterization of degradation products. Furlan M; Beck EA Biochim Biophys Acta; 1972 May; 263(3):631-44. PubMed ID: 4260762 [No Abstract] [Full Text] [Related]
8. Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals. Pisano JJ; Bronzert TJ; Peyton MP; Finlayson JS Ann N Y Acad Sci; 1972 Dec; 202():98-113. PubMed ID: 4629559 [No Abstract] [Full Text] [Related]
9. Titration of the acceptor cross-linking sites in fibrin. Lorand L; Chenoweth D; Gray A Ann N Y Acad Sci; 1972 Dec; 202():155-71. PubMed ID: 4508920 [No Abstract] [Full Text] [Related]
10. Use of a diimidoester cross-linking reagent to examine the subunit structure of rabbit muscle pyruvate kinase. Davies GE; Kaplan JG Can J Biochem; 1972 Apr; 50(4):416-22. PubMed ID: 5063715 [No Abstract] [Full Text] [Related]
12. The NH2-terminal amino acids of the fibrinogen degradation products. Implications for fibrinogen structure. Marder VJ; Budzynski AZ Thromb Diath Haemorrh Suppl; 1973; 56():127-35. PubMed ID: 4281939 [No Abstract] [Full Text] [Related]
13. Characterization of two complementary polypeptide chains obtained by proteolysis of rabbit muscle phosphorylase. Raibaud O; Goldberg ME Biochemistry; 1973 Dec; 12(25):5154-61. PubMed ID: 4799824 [No Abstract] [Full Text] [Related]
14. A molecular model for the proteolysis of human fibrinogen by plasmin. Mills DA Biochim Biophys Acta; 1972 May; 263(3):619-30. PubMed ID: 4260761 [No Abstract] [Full Text] [Related]
15. Bovine fibrinogen of relatively high solubility. II. Investigations on fraction I-6. Wuppermann T; Von Rosen G; Hörmann H Hoppe Seylers Z Physiol Chem; 1971 Dec; 352(12):1727-9. PubMed ID: 5169316 [No Abstract] [Full Text] [Related]